PUBLISHER: IMARC | PRODUCT CODE: 1702055
PUBLISHER: IMARC | PRODUCT CODE: 1702055
The global ECG telemetry devices market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.93% during 2025-2033.
Electrocardiography (ECG) telemetry devices enable rapid ECG monitoring of patients with suspected cardiovascular diseases (CVDs). They help detect electrical impulses generated by cardiac tissues, which are subsequently translated into waveforms. They find extensive applications in hospitals and home healthcare services. At present, the increasing prevalence of CVDs, such as heart attacks and strokes, due to alcohol and tobacco consumption, obesity, and physical inactivity among individuals is catalyzing the demand for ECG telemetry devices across the globe.
ECG telemetry devices are used in the diagnosis and treatment of arrhythmia wherein the heart rate of an individual becomes abnormal. These devices offer information about fluctuations in the rhythm of the heart that allows doctors to take required actions. Apart from this, ECG telemetry devices comprise resting ECGs, which are utilized for identifying conditions, such as coronary artery disease (CAD) or congestive heart failure (CHF). This, along with the thriving healthcare industry, is strengthening the growth of the market. Besides this, there is a significant rise in the utilization of health monitoring devices like electrocardiographs, digital thermometers, automatic blood pressure monitors, blood glucose monitors, and body fat monitors in the residential sector. They can be operated by patients or their caretakers with minimal training. Furthermore, coronavirus disease (COVID-19) affects the cardiovascular system and leads to myocardial damage and cardiac and endothelial dysfunction. This, coupled with the increasing geriatric population, is propelling the demand for ECG telemetry devices around the world. Other factors, including rising technological advancements and the growing awareness about cardiovascular health among the masses, are projected to influencing the overall sales and profitability positively in the coming years.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerotel Medical Systems (1998) Ltd., Compumed Inc., Hill-Rom Holdings Inc. (Baxter International Inc.), iRhythm Technologies Inc., Koninklijke Philips N.V., Medicalgorithmics S.A., Medtronic plc, Nihon Kohden Corporation, Preventice Solutions Inc. (Boston Scientific Corporation), ScottCare Cardiovascular Solutions, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and ZOLL Medical Corporation (Asahi Kasei Corporation).